FR2832710B1 - 5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS - Google Patents

5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS

Info

Publication number
FR2832710B1
FR2832710B1 FR0115342A FR0115342A FR2832710B1 FR 2832710 B1 FR2832710 B1 FR 2832710B1 FR 0115342 A FR0115342 A FR 0115342A FR 0115342 A FR0115342 A FR 0115342A FR 2832710 B1 FR2832710 B1 FR 2832710B1
Authority
FR
France
Prior art keywords
sulfanyl
medicaments
triazoles
derivatives
triazoles derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0115342A
Other languages
French (fr)
Other versions
FR2832710A1 (en
Inventor
Marie Odile Galcera
Alban Sidhu
Pierre Roubert
Christophe Thurieau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0115342A priority Critical patent/FR2832710B1/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to RU2004119406/04A priority patent/RU2367655C2/en
Priority to ES02796876T priority patent/ES2330927T3/en
Priority to US10/496,820 priority patent/US20050154039A1/en
Priority to BR0214553-7A priority patent/BR0214553A/en
Priority to JP2003547378A priority patent/JP2005513035A/en
Priority to MXPA04005099A priority patent/MXPA04005099A/en
Priority to AT02796876T priority patent/ATE438630T1/en
Priority to NZ533397A priority patent/NZ533397A/en
Priority to CZ2004760A priority patent/CZ2004760A3/en
Priority to CA002468184A priority patent/CA2468184A1/en
Priority to TW091134432A priority patent/TWI283670B/en
Priority to DE60233265T priority patent/DE60233265D1/en
Priority to AU2002361345A priority patent/AU2002361345B8/en
Priority to KR1020047008002A priority patent/KR100961332B1/en
Priority to PL02370140A priority patent/PL370140A1/en
Priority to EP02796876A priority patent/EP1465880B1/en
Priority to CNB028276248A priority patent/CN100462359C/en
Priority to HU0402489A priority patent/HUP0402489A3/en
Priority to PCT/FR2002/004055 priority patent/WO2003045926A1/en
Priority to MYPI20024450A priority patent/MY133406A/en
Priority to ARP020104601A priority patent/AR037465A1/en
Publication of FR2832710A1 publication Critical patent/FR2832710A1/en
Priority to NO20042635A priority patent/NO20042635L/en
Publication of FR2832710B1 publication Critical patent/FR2832710B1/en
Application granted granted Critical
Priority to HK05103025.8A priority patent/HK1070361A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0115342A 2001-11-28 2001-11-28 5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS Expired - Fee Related FR2832710B1 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR0115342A FR2832710B1 (en) 2001-11-28 2001-11-28 5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS
MYPI20024450A MY133406A (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
US10/496,820 US20050154039A1 (en) 2001-11-28 2002-11-27 5-Sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
BR0214553-7A BR0214553A (en) 2001-11-28 2002-11-27 Compounds, process of liquid phase preparation of compounds and pharmaceutical compositions
JP2003547378A JP2005513035A (en) 2001-11-28 2002-11-27 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as pharmaceuticals
MXPA04005099A MXPA04005099A (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine.
AT02796876T ATE438630T1 (en) 2001-11-28 2002-11-27 5-SULFANYL-4H-1,2,4-TRIAZOLE DERIVATIVES AND THE USE THEREOF FOR TREATING SOMATOSTATIN-MEDIATED DISEASES
NZ533397A NZ533397A (en) 2001-11-28 2002-11-27 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament
CZ2004760A CZ2004760A3 (en) 2001-11-28 2002-11-27 5-Sulfanyl-4H-1,2,4-triazole derivatives, process of their preparation and their use as a medicament
CA002468184A CA2468184A1 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
TW091134432A TWI283670B (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
DE60233265T DE60233265D1 (en) 2001-11-28 2002-11-27 5-Sulphinyl-4H-1,2,4-triazole derivatives and their use in the treatment of somatostatin-mediated diseases
RU2004119406/04A RU2367655C2 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivative and their use as medicinal agents
AU2002361345A AU2002361345B8 (en) 2001-11-28 2002-11-27 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
PCT/FR2002/004055 WO2003045926A1 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
EP02796876A EP1465880B1 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
CNB028276248A CN100462359C (en) 2001-11-28 2002-11-27 5-sulfanyl-4H-1,2,4-triazole derivatives and their use as a medicament
HU0402489A HUP0402489A3 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
PL02370140A PL370140A1 (en) 2001-11-28 2002-11-27 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
ES02796876T ES2330927T3 (en) 2001-11-28 2002-11-27 DERIVATIVES OF 5-SULFANIL-4H-1,2,4-TRIAZOLS TO TREAT SOMATOSTATIN ASSOCIATED DISORDERS.
KR1020047008002A KR100961332B1 (en) 2001-11-28 2002-11-27 5-Sulphanyl-4H-1,2,4-Triazole Derivatives and Their Use as Medicine
ARP020104601A AR037465A1 (en) 2001-11-28 2002-11-28 COMPOSITE DERIVED FROM 5-SULFANIL-4H-1,2,4-TRIAZOL, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCESS FOR ITS PREPARATION IN THE LIQUID PHASE
NO20042635A NO20042635L (en) 2001-11-28 2004-06-23 5-Sulfanyl-HH-1,2,4-triazole derivatives and their use as medicine
HK05103025.8A HK1070361A1 (en) 2001-11-28 2005-04-11 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0115342A FR2832710B1 (en) 2001-11-28 2001-11-28 5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS

Publications (2)

Publication Number Publication Date
FR2832710A1 FR2832710A1 (en) 2003-05-30
FR2832710B1 true FR2832710B1 (en) 2004-09-03

Family

ID=8869847

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115342A Expired - Fee Related FR2832710B1 (en) 2001-11-28 2001-11-28 5-SULFANYL-4H-1,2,4-TRIAZOLES DERIVATIVES AND THEIR USE AS MEDICAMENTS

Country Status (1)

Country Link
FR (1) FR2832710B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1086086T3 (en) * 1998-06-12 2005-01-24 Sod Conseils Rech Applic Imidazolyl derivatives and their use as somatostatin receptor ligands
FR2796945B1 (en) * 1999-07-30 2002-06-28 Sod Conseils Rech Applic NOVEL DERIVATIVES OF HYDANTOINS, THIOHYDANTOINS, PYRIMIDINEDIONES AND THIOXOPYRIMIDINONES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2802206B1 (en) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic 4-AMINOPIPERIDINE DERIVATIVES AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
FR2832710A1 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
DK1263720T3 (en) Acetidine derivatives, their preparation, and pharmaceutical compositions containing the same
DE60019577D1 (en) 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUM-AGENT
EE200200175A (en) Substituted 2-Thio-3,5-Dicyano-4-aryl-6-aminopyridines and their Uses
NO20014963L (en) Cycloalkyl-substituted benzimidazoles, as well as the preparation and use thereof
FR2802206B1 (en) 4-AMINOPIPERIDINE DERIVATIVES AND THEIR USE AS MEDICINAL PRODUCTS
DE69838405D1 (en) Microstructured, cosmetically acceptable compositions
DE69907964D1 (en) 1,2-FELLENED CHINOLINE DERIVATIVES
NO20032909L (en) Glucopyranosyloxypyrazole derivatives as well as their drug use
DE69824632D1 (en) PURINE DERIVATIVES AND MEDICATIONS, WHICH CONTAIN THE SAME AS AN ACTIVE INGREDIENT
IT1308096B1 (en) TILTROTOR
MA26599A1 (en) NOVEL BENZENESULFONYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
ID29089A (en) MOKSIFLOXASIN PHARMACEUTICAL PROPERTIES
HUP0400540A3 (en) 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them
EE200100009A (en) Benzimidazoles, their preparation and use as medicaments
CY2013003I1 (en) PHOSPHONOCHEMICAL DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF
EE200300311A (en) Phthalazinone-piperidine derivatives, their use and medicine
ATE228510T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
EE200000037A (en) Acylpiperazinylpyrimidines Derivatives, Their Preparation and Use as Medicaments
DE59905572D1 (en) SUBSTITUTED 4-AMINO-2-ARYL-PYRIMIDINE, THEIR PRODUCTION, THEIR USE AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
FR2806720B1 (en) 2,2,6,6-DIETHYL-DIMETHYL-1-ALCOXYPIPERIDINE DERIVATIVES AND CORRESPONDING 1-OXIDES
ATE315036T1 (en) 2,4-DIAMINOPYRIMIDENE DERIVATIVES AS IMMUNOSUPPRESSANTS
IS5730A (en) Substituted thiazolo-pyridazine derivatives, pharmaceutical formulations thereof
DE60006958D1 (en) STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND THE PREPARATIONS THEREOF
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20120731